Treatment of Vitamin D Deficiency in Predominantly Hispanic and Black Adolescents: A Randomized Clinical Trial

Hina J. Talib, Tulasi Ponnapakkam, Robert Gensure, Hillel W. Cohen, Susan M. Coupey

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives To compare 3 different treatment regimens for Vitamin D deficiency in minority adolescents and to explore factors that impact treatment efficacy. Study design We conducted an 8-week, prospective, open-label, randomized clinical trial in an urban, academic, children's hospital. A total of 183 Vitamin D-deficient adolescents, mean 25-hydroxyVitamin D or 25(OH)D 13.7 ± 3.9 ng/mL; mean age 16.6 ± 2.2 years, were randomized into 3 Vitamin D3 (cholecalciferol) treatment arms: 50 000 IU/wk; 5000 IU/d; and 1000 IU/d. Serum 25(OH)D and Vitamin D binding protein (VDBP) levels were measured pre-and posttreatment; 122 (67%) participants completed posttreatment measures. Complete-case and multiple-imputation, intention-to-treat analyses were performed. Results Mean change in 25(OH)D level posttreatment was significantly different among the 3 arms, 24.9 ± 15.1 vs 21.0 ± 15.2 vs 6.2 ± 6.5 ng/mL, for 50 000 IU, 5000 IU, and 1000 IU doses, respectively, P 30 ng/mL) with 50 000 IU, 5000 IU, and 1000 IU doses, respectively, P

Original languageEnglish (US)
Pages (from-to)266-272e1
JournalJournal of Pediatrics
Volume170
DOIs
StatePublished - Mar 1 2016

Fingerprint

Vitamin D Deficiency
Cholecalciferol
Hispanic Americans
Randomized Controlled Trials
Vitamin D-Binding Protein
Intention to Treat Analysis
Vitamin D
Therapeutics
Serum
P-30 composite resin
25-hydroxyvitamin D

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Treatment of Vitamin D Deficiency in Predominantly Hispanic and Black Adolescents : A Randomized Clinical Trial. / Talib, Hina J.; Ponnapakkam, Tulasi; Gensure, Robert; Cohen, Hillel W.; Coupey, Susan M.

In: Journal of Pediatrics, Vol. 170, 01.03.2016, p. 266-272e1.

Research output: Contribution to journalArticle

@article{a643aaf54d2e444e83b9dbb5969140a6,
title = "Treatment of Vitamin D Deficiency in Predominantly Hispanic and Black Adolescents: A Randomized Clinical Trial",
abstract = "Objectives To compare 3 different treatment regimens for Vitamin D deficiency in minority adolescents and to explore factors that impact treatment efficacy. Study design We conducted an 8-week, prospective, open-label, randomized clinical trial in an urban, academic, children's hospital. A total of 183 Vitamin D-deficient adolescents, mean 25-hydroxyVitamin D or 25(OH)D 13.7 ± 3.9 ng/mL; mean age 16.6 ± 2.2 years, were randomized into 3 Vitamin D3 (cholecalciferol) treatment arms: 50 000 IU/wk; 5000 IU/d; and 1000 IU/d. Serum 25(OH)D and Vitamin D binding protein (VDBP) levels were measured pre-and posttreatment; 122 (67{\%}) participants completed posttreatment measures. Complete-case and multiple-imputation, intention-to-treat analyses were performed. Results Mean change in 25(OH)D level posttreatment was significantly different among the 3 arms, 24.9 ± 15.1 vs 21.0 ± 15.2 vs 6.2 ± 6.5 ng/mL, for 50 000 IU, 5000 IU, and 1000 IU doses, respectively, P 30 ng/mL) with 50 000 IU, 5000 IU, and 1000 IU doses, respectively, P",
author = "Talib, {Hina J.} and Tulasi Ponnapakkam and Robert Gensure and Cohen, {Hillel W.} and Coupey, {Susan M.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.jpeds.2015.11.025",
language = "English (US)",
volume = "170",
pages = "266--272e1",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Treatment of Vitamin D Deficiency in Predominantly Hispanic and Black Adolescents

T2 - A Randomized Clinical Trial

AU - Talib, Hina J.

AU - Ponnapakkam, Tulasi

AU - Gensure, Robert

AU - Cohen, Hillel W.

AU - Coupey, Susan M.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Objectives To compare 3 different treatment regimens for Vitamin D deficiency in minority adolescents and to explore factors that impact treatment efficacy. Study design We conducted an 8-week, prospective, open-label, randomized clinical trial in an urban, academic, children's hospital. A total of 183 Vitamin D-deficient adolescents, mean 25-hydroxyVitamin D or 25(OH)D 13.7 ± 3.9 ng/mL; mean age 16.6 ± 2.2 years, were randomized into 3 Vitamin D3 (cholecalciferol) treatment arms: 50 000 IU/wk; 5000 IU/d; and 1000 IU/d. Serum 25(OH)D and Vitamin D binding protein (VDBP) levels were measured pre-and posttreatment; 122 (67%) participants completed posttreatment measures. Complete-case and multiple-imputation, intention-to-treat analyses were performed. Results Mean change in 25(OH)D level posttreatment was significantly different among the 3 arms, 24.9 ± 15.1 vs 21.0 ± 15.2 vs 6.2 ± 6.5 ng/mL, for 50 000 IU, 5000 IU, and 1000 IU doses, respectively, P 30 ng/mL) with 50 000 IU, 5000 IU, and 1000 IU doses, respectively, P

AB - Objectives To compare 3 different treatment regimens for Vitamin D deficiency in minority adolescents and to explore factors that impact treatment efficacy. Study design We conducted an 8-week, prospective, open-label, randomized clinical trial in an urban, academic, children's hospital. A total of 183 Vitamin D-deficient adolescents, mean 25-hydroxyVitamin D or 25(OH)D 13.7 ± 3.9 ng/mL; mean age 16.6 ± 2.2 years, were randomized into 3 Vitamin D3 (cholecalciferol) treatment arms: 50 000 IU/wk; 5000 IU/d; and 1000 IU/d. Serum 25(OH)D and Vitamin D binding protein (VDBP) levels were measured pre-and posttreatment; 122 (67%) participants completed posttreatment measures. Complete-case and multiple-imputation, intention-to-treat analyses were performed. Results Mean change in 25(OH)D level posttreatment was significantly different among the 3 arms, 24.9 ± 15.1 vs 21.0 ± 15.2 vs 6.2 ± 6.5 ng/mL, for 50 000 IU, 5000 IU, and 1000 IU doses, respectively, P 30 ng/mL) with 50 000 IU, 5000 IU, and 1000 IU doses, respectively, P

UR - http://www.scopus.com/inward/record.url?scp=84960435958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960435958&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2015.11.025

DO - 10.1016/j.jpeds.2015.11.025

M3 - Article

C2 - 26707619

AN - SCOPUS:84960435958

VL - 170

SP - 266-272e1

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

ER -